B & T Capital Management DBA Alpha Capital Management Purchases New Stake in Grail, Inc. (NASDAQ:GRAL)

B & T Capital Management DBA Alpha Capital Management bought a new stake in Grail, Inc. (NASDAQ:GRALFree Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 21,684 shares of the company’s stock, valued at approximately $387,000. B & T Capital Management DBA Alpha Capital Management owned approximately 0.06% of Grail at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in GRAL. 180 Wealth Advisors LLC acquired a new stake in shares of Grail in the 4th quarter valued at approximately $1,681,000. FNY Investment Advisers LLC bought a new stake in shares of Grail during the fourth quarter worth $26,000. A. D. Beadell Investment Counsel Inc. acquired a new position in shares of Grail during the fourth quarter worth $430,000. Finally, Douglas Lane & Associates LLC bought a new position in shares of Grail in the 4th quarter valued at $3,034,000.

Insider Activity

In other Grail news, CFO Aaron Freidin sold 30,452 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the sale, the chief financial officer now directly owns 268,277 shares in the company, valued at approximately $3,761,243.54. This trade represents a 10.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Guggenheim initiated coverage on Grail in a research report on Thursday, October 17th. They set a “neutral” rating on the stock. Wolfe Research assumed coverage on Grail in a research note on Friday, November 15th. They issued a “peer perform” rating for the company. Finally, Morgan Stanley assumed coverage on shares of Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price on the stock.

Read Our Latest Stock Report on Grail

Grail Trading Up 0.1 %

Shares of GRAL stock opened at $17.42 on Friday. Grail, Inc. has a one year low of $12.33 and a one year high of $24.92. The firm has a 50 day moving average of $18.32.

About Grail

(Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Featured Stories

Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Grail, Inc. (NASDAQ:GRALFree Report).

Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.